Andrew Schiermeier
Chief Executive Officer at AvenCell Therapeutics, Inc.
Andrew Schiermeier active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Kynan Pharmaceuticals | Director/Board Member | - | - |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Board Member | 2021-07-31 | - |
| Chief Executive Officer | 2021-07-31 | - | |
Regel Therapeutics Inc.
 Regel Therapeutics Inc. BiotechnologyHealth Technology Regel Therapeutics Inc. develops a proprietary technology platform related to gene therapy. The company is based in Cambridge, MA. The company was founded in 2020 by Navneet Matharu, Jordane Dimidschstein, Steven B. Ruchefsky, Michael Jasulavic, Orrin Devinsky. Steven B. Ruchefsky has been the CEO since 2020. | Director/Board Member | - | - |
Career history of Andrew Schiermeier
Former positions of Andrew Schiermeier
| Companies | Position | Start | End |
|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Chief Operating Officer | - | 2021-06-20 |
| Corporate Officer/Principal | 2018-03-31 | - | |
| MERCK KGAA | Corporate Officer/Principal | 2013-04-30 | 2015-12-31 |
| AURA BIOSCIENCES, INC. | Chief Operating Officer | 2010-12-31 | 2013-04-30 |
Training of Andrew Schiermeier
| Harvard University | Doctorate Degree |
| Stanford University | Graduate Degree |
| College des Ingenieurs | Masters Business Admin |
Statistics
International
| United States | 8 |
| Germany | 2 |
| France | 2 |
Operational
| Director/Board Member | 3 |
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK KGAA | Health Technology |
| AURA BIOSCIENCES, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Kynan Pharmaceuticals | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
Regel Therapeutics Inc.
Regel Therapeutics Inc. BiotechnologyHealth Technology Regel Therapeutics Inc. develops a proprietary technology platform related to gene therapy. The company is based in Cambridge, MA. The company was founded in 2020 by Navneet Matharu, Jordane Dimidschstein, Steven B. Ruchefsky, Michael Jasulavic, Orrin Devinsky. Steven B. Ruchefsky has been the CEO since 2020. | Health Technology |
- Stock Market
- Insiders
- Andrew Schiermeier
- Experience
